Momenta to Present at the Bank of America Merrill Lynch 2012 Health Care Conference - Momenta Pharmaceuticals
Alnylam Presents Final Results from a Phase I Clinical Trial of ALN-TTR01, an RNAi Therapeutic Targeting Transthyretin (TTR) for the Treatment of Transthyretin-Mediated Amyloidosis (ATTR) - Alnylam
athenahealth Named to Forbes' List of America's 25 Fastest-Growing Tech Companies - AthenaHealth
